Identification of a glycolysis‐related gene signature for survival prediction of ovarian cancer patients-Reference-Cited by-同舟云学术

Identification of a glycolysis‐related gene signature for survival prediction of ovarian cancer patients

Published:2021-10-05 Issue:22 Volume:10 Page:8222-8237
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Zhang Dai¹²,Li Yiche³,Yang Si¹,Wang Meng¹,Yao Jia⁴,Zheng Yi¹^ORCID,Deng Yujiao¹,Li Na¹,Wei Bajin⁴,Wu Ying¹⁴,Zhai Zhen¹,Dai Zhijun⁴^ORCID,Kang Huafeng¹

Affiliation:

1. Department of Oncology The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an China

2. Department of Thyroid, Breast and Vascular Surgery Xijing HospitalThe Air Force Medical University Xi'an China

3. Department of Tumor Surgery Shaanxi Provincial People's Hospital Xi'an China

4. Department of Breast Surgery The First Affiliated HospitalCollege of MedicineZhejiang University Hangzhou China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4317

Reference108 articles.

1. Cancer statistics, 2019

2. Current state of biomarkers in ovarian cancer prognosis

3. Who are the long-term survivors of high grade serous ovarian cancer?

4. Prognostic significance of high metabolic activity in breast cancer: PET signature in breast cancer

5. Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single‑cell RNA sequencing reveals heterogeneity in ovarian cancer and constructs a prognostic signature for prognostic prediction and immunotherapy;International Immunopharmacology;2024-10

2. TCEB2/HIF1A signaling axis promotes chemoresistance in ovarian cancer cells by enhancing glycolysis and angiogenesis;European Journal of Medical Research;2024-09-11

3. FOSL2-mediated transcription of ISG20 induces M2 polarization of macrophages and enhances tumorigenic ability of glioblastoma cells;Journal of Neuro-Oncology;2024-07-29

4. TGFBI: A novel therapeutic target for cancer;International Immunopharmacology;2024-06

5. TGF β1 promotes the polarization of M2-type macrophages and activates PI3K/mTOR signaling pathway by inhibiting ISG20 to sensitize ovarian cancer to cisplatin;International Immunopharmacology;2024-06